[1] |
RAJAKUMAR T, HOROS R, JEHN J, et al. A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy[J]. NPJ Precis Oncol, 2022, 6(1): 19. DOI: 10.1038/s41698-022-00262-y.
|
[2] |
TU Y, GUO R, LI J, et al. miRNA regulation of MIF in SLE and attenuation of murine lupus nephritis with miR-654[J]. Front Immunol, 2019, 10: 2229. DOI: 10.3389/fimmu.2019.02229.
|
[3] |
HU J, HUANG S, LIU X, et al. miR-155: an important role in inflammation response[J]. J Immunol Res, 2022: 7437281. DOI: 10.1155/2022/7437281.
|
[4] |
MATIAS-GARCIA PR, WILSON R, MUSSACK V, et al. Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples[J]. PLoS One, 2020, 15(1): e0227648. DOI: 10.1371/journal.pone.0227648.
|
[5] |
DI STEFANO AB, PAPPALARDO M, MOSCHELLA F, et al. MicroRNAs in solid organ and vascularized composite allotransplantation: potential biomarkers for diagnosis and therapeutic use[J]. Transplant Rev (Orlando), 2020, 34(4): 100566. DOI: 10.1016/j.trre.2020.100566.
|
[6] |
WANG X, ZHANG R, HUANG Z, et al. Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells[J]. Transpl Immunol, 2021, 69: 101461. DOI: 10.1016/j.trim.2021.101461.
|
[7] |
LI GS, CUI L, WANG GD. miR-155-5p regulates macrophage M1 polarization and apoptosis in the synovial fluid of patients with knee osteoarthritis[J]. Exp Ther Med, 2021, 21(1): 68. DOI: 10.3892/etm.2020.9500.
|
[8] |
SUN W, ZHANG L, LIN L, et al. Chronic psychological stress impairs germinal center response by repressing miR-155[J]. Brain Behav Immun, 2019, 76: 48-60. DOI: 10.1016/j.bbi.2018.11.002.
|
[9] |
ARBORE G, HENLEY T, BIGGINS L, et al. MicroRNA-155 is essential for the optimal proliferation and survival of plasmablast B cells[J]. Life Sci Alliance, 2019, 2(3): e201800244. DOI: 10.26508/lsa.201800244.
|
[10] |
GUO J, LIAO M, WANG J. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155[J]. Cell Commun Signal, 2021, 19(1): 90. DOI: 10.1186/s12964-021-00771-6.
|
[11] |
TANG B, WANG Z, QI G, et al. MicroRNA-155 deficiency attenuates ischemia-reperfusion injury after liver transplantation in mice[J]. Transpl Int, 2015, 28(6): 751-760. DOI: 10.1111/tri.12528.
|
[12] |
KIM HJ, PARK SO, BYEON HW, et al. T cell-intrinsic miR-155 is required for Th2 and Th17-biased responses in acute and chronic airway inflammation by targeting several different transcription factors[J]. Immunology, 2022, 116(3): 357-359. DOI: 10.1111/imm.13477.
|
[13] |
JIANG K, YANG J, GUO S, et al. Peripheral circulating exosome-mediated delivery of miR-155 as a novel mechanism for acute lung inflammation[J]. Mol Ther, 2019, 27(10): 1758-1771. DOI: 10.1016/j.ymthe.2019.07.003.
|
[14] |
RENRICK AN, THOUNAOJAM MC, DE AQUINO MTP, et al. Bortezomib sustains T cell function by inducing miR-155-mediated downregulation of SOCS1 and SHIP1[J]. Front Immunol, 2021, 12: 607044. DOI: 10.3389/fimmu.2021.607044.
|
[15] |
LI J, GONG J, LI P, et al. Knockdown of microRNA-155 in Kupffer cells results in immunosuppressive effects and prolongs survival of mouse liver allografts[J]. Transplantation, 2014, 97(6): 626-635. DOI: 10.1097/TP.0000000000000061.
|
[16] |
TENG C, LIN C, HUANG F, et al. Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease[J]. Acta Pharm Sin B, 2020, 10(8): 1521-1533. DOI: 10.1016/j.apsb.2020.06.005.
|
[17] |
LI J, ZHANG J, GUO H, et al. Critical role of alternative M2 skewing in miR-155 deletion-mediated protection of colitis[J]. Front Immunol, 2018, 9: 904. DOI: 10.3389/fimmu.2018.00904.
|
[18] |
MARTINEZ-NUNEZ RT, LOUAFI F, FRIEDMANN PS, et al. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)[J]. J Biol Chem, 2009, 284(24): 16334-16342. DOI: 10.1074/jbc.M109.011601.
|
[19] |
VAN AELST LN, SUMMER G, LI S, et al. RNA profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection[J]. Am J Transplant, 2016, 16(1): 99-110. DOI: 10.1111/ajt.13421.
|
[20] |
CEPPI M, PEREIRA PM, DUNAND-SAUTHIER I, et al. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells[J]. Proc Natl Acad Sci U S A, 2009, 106(8): 2735-2740. DOI: 10.1073/pnas.0811073106.
|
[21] |
ZHANG A, WANG K, ZHOU C, et al. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection[J]. J Heart Lung Transplant, 2017, 36(2): 175-184. DOI: 10.1016/j.healun.2016.04.018.
|
[22] |
ZITZER NC, SNYDER K, MENG X, et al. MicroRNA-155 modulates acute graft-versus-host disease by impacting T cell expansion, migration, and effector function[J]. J Immunol, 2018, 200(12): 4170-4179. DOI: 10.4049/jimmunol.1701465.
|
[23] |
WANG J, LI K, ZHANG X, et al. MicroRNA-155 controls iNKT cell development and lineage differentiation by coordinating multiple regulating pathways[J]. Front Cell Dev Biol, 2021, 8: 619220. DOI: 10.3389/fcell.2020.619220.
|
[24] |
HUANG H, HE J, TENG X, et al. Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression[J]. J Surg Res, 2013, 185(2): 896-903. DOI: 10.1016/j.jss.2013.06.015.
|
[25] |
LU D, NAKAGAWA R, LAZZARO S, et al. The miR-155-PU. 1 axis acts on Pax5 to enable efficient terminal B cell differentiation[J]. J Exp Med, 2014, 211(11): 2183-2198. DOI: 10.1084/jem.20140338.
|
[26] |
ALSAADI M, KHAN MY, DALHAT MH, et al. Dysregulation of miRNAs in DLBCL: causative factor for pathogenesis, diagnosis and prognosis[J]. Diagnostics (Basel), 2021, 11(10): 1739. DOI: 10.3390/diagnostics11101739.
|
[27] |
FARRONI C, MARASCO E, MARCELLINI V, et al. Dysregulated miR-155 and miR-125b are related to impaired B-cell responses in down syndrome[J]. Front Immunol, 2018, 9: 2683. DOI: 10.3389/fimmu.2018.02683.
|
[28] |
MILLÁN O, RUIZ P, ORTS L, et al. Monitoring of miR-181a-5p and miR-155-5p plasmatic expression as prognostic biomarkers for acute and subclinical rejection in de novo adult liver transplant recipients[J]. Front Immunol, 2019, 10: 873. DOI: 10.3389/fimmu.2019.00873.
|
[29] |
RUIZ P, MILLÁN O, RÍOS J, et al. MicroRNAs 155-5p, 122-5p, and 181a-5p identify patients with graft dysfunction due to T cell-mediated rejection after liver transplantation[J]. Liver Transpl, 2020, 26(10): 1275-1286. DOI: 10.1002/lt.25842.
|
[30] |
TINEL C, LAMARTHÉE B, CALLEMEYN J, et al. Integrative omics analysis unravels microvascular inflammation-related pathways in kidney allograft biopsies[J]. Front Immunol, 2021, 12: 738795. DOI: 10.3389/fimmu.2021.738795.
|
[31] |
XIU MX, LIU ZT, TANG J. Screening and identification of key regulatory connections and immune cell infiltration characteristics for lung transplant rejection using mucosal biopsies[J]. Int Immunopharmacol, 2020, 87: 106827. DOI: 10.1016/j.intimp.2020.106827.
|
[32] |
GIELIS EM, ANHOLTS JDH, VAN BEELEN E, et al. A combined microRNA and chemokine profile in urine to identify rejection after kidney transplantation[J]. Transplant Direct, 2021, 7(7): e711. DOI: 10.1097/TXD.0000000000001169.
|
[33] |
LIN Y, WANG L, GE W, et al. Multi-omics network characterization reveals novel microRNA biomarkers and mechanisms for diagnosis and subtyping of kidney transplant rejection[J]. J Transl Med, 2021, 19(1): 346. DOI: 10.1186/s12967-021-03025-8.
|
[34] |
ESMAEILI-BANDBONI A, BAGHERI J, BAKHSHANDEH AR, et al. Serum levels of miR-155, miR-326, and miR-133b as early diagnostic biomarkers for the detection of human acute heart allograft rejection in comparison with serum cardiac troponin T[J]. Heart Surg Forum, 2018, 21(2): E101-E107. DOI: 10.1532/hsf.1887.
|
[35] |
BOZZINI S, DEL FANTE C, MOROSINI M, et al. Mechanisms of action of extracorporeal photopheresis in the control of bronchiolitis obliterans syndrome (BOS): involvement of circulating miRNAs[J]. Cells, 2022, 11(7): 1117. DOI: 10.3390/cells11071117.
|
[36] |
SOLTANINEJAD E, NICKNAM MH, NAFAR M, et al. Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection[J]. Transpl Immunol, 2015, 33(1): 1-6. DOI: 10.1016/j.trim.2015.05.002.
|
[37] |
PALADINI SV, PINTO GH, BUENO RH, et al. Identification of candidate biomarkers for transplant rejection from transcriptome data: a systematic review[J]. Mol Diagn Ther, 2019, 23(4): 439-458. DOI: 10.1007/s40291-019-00397-y.
|